Search Results for: Lewy

October 4, 2024October 4, 2024

Correlation between dopaminergic and metabolic asymmetry in Lewy body disease – A dual-imaging study.

Publication date: Oct 01, 2024 The a-Synuclein Origin and Connectome (SOC) model of Lewy body diseases postulates that a-syuclein will be asymmetrically distributed in some patients with Lewy body diseases, ... Read more

October 2, 2024October 2, 2024

Measuring Cognition in Clinical Trials in Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders: Roundtable Proceedings and Roadmap for Research.

Parkinson's Disease Literature

Publication date: Sep 01, 2024 Emerging research suggests that Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) share underlying pathology and may represent a single, biologically defined disease spectrum. ... Read more

September 23, 2024September 23, 2024

Relationships between neuroimaging biomarkers and glymphatic-system activity in dementia with Lewy bodies.

Parkinson's Disease Literature

Publication date: Sep 20, 2024 Alpha-synuclein deposits in the brain have been suspected to cause Parkinson’s disease and dementia with Lewy bodies (DLB). It was recently revealed that the glymphatic ... Read more

September 17, 2024September 17, 2024

Scientists find important causes of Parkinson’s disease and Lewy body dementia

Parkinson's Disease News

Publication date: Sep 17, 2024 However, in people with Parkinsons and LBD, this protein builds up in sticky clumps, damaging brain cells. Further research in this area could lead to ... Read more

September 11, 2024September 11, 2024

Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?

Parkinson's Disease Literature

Publication date: Sep 10, 2024 The term rapidly progressive dementia (RPD) with Lewy bodies (rpDLB) is used for DLB patients who develop a rapidly progressive neurological syndrome and have reduced ... Read more

September 1, 2024September 1, 2024

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies.

Parkinson's Disease Literature

Publication date: Aug 30, 2024 Glucocerebrosidase 1 (GBA1) mutations are associated with reduced survival in Parkinson’s disease but their effect on survival in dementia with Lewy bodies (DLB) is unclear. ... Read more

September 1, 2024September 1, 2024

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies.

Parkinson's Disease Literature

August 19, 2024August 19, 2024

Spatial-temporal dynamic evolution of lewy body dementia by metabolic PET imaging.

Parkinson's Disease Literature

Publication date: Aug 19, 2024 Lewy body dementia (LBD) is a neurodegenerative disease with high heterogeneity and complex pathogenesis. Our study aimed to use disease progression modeling to uncover spatial-temporal ... Read more

August 16, 2024August 16, 2024

CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder.

Parkinson's Disease Literature

Publication date: Aug 15, 2024 We investigated the biomarker profile of neurodegeneration, Alzheimer’s and Lewy body pathology in the CSF of 148 polysomnography-confirmed patients with isolated REM sleep behavior disorder ... Read more

August 13, 2024August 13, 2024

Neurovascular health and Lewy body disorders, where is the connection?

Parkinson's Disease Media

Publication date: Aug 12, 2024 Studies have shown a close interplay between the cerebrovascular system and neurodegeneration. But what is the current evidence, and how can it help us better ... Read more